Moderna (MRNA) CEO Stéphane Bancel partly credited the U.S. for the company’s rapid development of a COVID-19 vaccine candidate, telling Yahoo Finance on Monday it could not have participated in such a robust trial without the federal government’s support.
The U.S.’s leading coronavirus vaccine candidate — one of several companies that are part of Operation Warp Speed — entered Phase 3 trials Monday, with hopes of results by October or November. Bancel cited the additional $472…
Source link
